Psyched Wellness Announces Secured Term Loan
Toronto, Ontario--(Newsfile Corp. - August 5, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together the "Lenders") for an aggregate principal am
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-08-05 9:00 AM EDT | Psyched Wellness Ltd.
Orange Insurance Services Surpasses Launch Goal Ahead of August Market Debut
Chicago, Illinois--(Newsfile Corp. - August 5, 2026) - Orange Underwriters, LLC DBA Orange Insurance Services ("Orange"), a technology-driven managing general agency (MGA) focused on Florida's non-standard personal automobile insurance market, today announced that it has exceeded a major pre-launch milestone by securing commitments from 50 independent insurance agencies ahead of its planned August launch. Based on the strong pace of appointments and growing market demand, the company n
2026-08-05 9:00 AM EDT | HPN Holdings, Inc.
Britannia Announces Normal Course Issuer Bid
Toronto, Ontario--(Newsfile Corp. - August 5, 2026) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") announces that further to its news release dated May 21, 2026, the Company will commence a normal course issuer bid ("NCIB") to purchase for cancelation, from time to time over a 12-month period starting August 10, 2026, common shares ("Common Shares") of the Company in an aggregate amount of up to 8,112,717 Common Shares, representing 5% of Britannia's issued and outs
Biotechnology, Household / Consumer / Cosmetics, Health, Cannabis Ancillary Service Provider
2026-08-05 8:30 AM EDT | Britannia Life Sciences Inc
Custom Health to Acquire Spencer Health Solutions, Strengthening Its Medication Management Infrastructure at Home
Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's pharmacist-led medication management platform with the spencer® in-home smart dispensing and monitoring system, bringing an important in-home medication technology capability fully in-house and further strengthening Custom Health's medication management at home. The Transaction is expected to expand the Corporation's margins by elimi
Technology, Pharmaceuticals, Health
2026-08-05 6:00 AM EDT | Custom Health Holdings Inc.
Rhelion Life Sciences Corp. Commences Trading Under New Name and Ticker Symbol RHEL on the CSE
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (OTCQB: TRUFF) (FSE: 4YX) ("Rhelion" or the "Company") is pleased to announce that it has completed its corporate name change from Red Light Holland Corp. to Rhelion Life Sciences Corp. and changed its ticker symbol on the Canadian Securities Exchange (the "CSE") from "TRIP" to "RHEL" (collectively, the "Name and Ticker Change"). The Company's common shares (the "
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-04 9:00 PM EDT | Rhelion Life Sciences Corp.
PreveCeutical Closes Fourth Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated July 27, 2026, June 12, 2026, May 12, 2026 and April 22, 2026 (the "Prior News Releases"), it has closed a fourth tranche (the "Fourth Tranche") of its previously announced non-brokered private placement (the "Offering"),
Biotechnology, Pharmaceuticals, Health
2026-08-04 5:20 PM EDT | PreveCeutical Medical Inc.
AAMI Announces neXus 2027 Advisory Council and Location
Arlington, Virginia--(Newsfile Corp. - August 4, 2026) - The Association for the Advancement of Medical Instrumentation (AAMI) officially announces the members of its Advisory Council and location for the leading medical device industry standards conference held in 2027. The 2027 AAMI neXus will be the premier gathering of the medical device, safety, and regulato
2026-08-04 8:50 AM EDT | Association for the Advancement of Medical Instrumentation
Glow Lifetech Announces Expansion into Quebec, Marking Significant New Market Opportunity in National Growth Strategy
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce its expansion into the Quebec cannabis market, launching its .decimal™ brand across the province beginning August 2026. The expansion marks the Company's entry into one of Canada's largest and most strategically important cannabis markets and represents a significant milestone in Glow's national expansion strategy.
2026-08-04 7:30 AM EDT | Glow Lifetech Corp.
TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback
Clearwater, Florida--(Newsfile Corp. - August 4, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF), a technology-enabled healthcare and digital pharmacy platform, today announced the launch of its new brand platform and digital experience, designed around the needs of modern patients. Shaped by insights gathered from patients over the past two years, the launch represents a significant investment in building a healthcare bra
Healthcare and Hospitals, Health
2026-08-04 7:30 AM EDT | TelyRx
Rise Nano Optics Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) ("Rise" or the "Company") a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that its common shares have been approved to commence trading on the OTCQB Venture Market, operated by OTC Markets Group Inc. The Company's common shares are also now DTC eligible, enhancing the accessibilit
2026-08-04 7:00 AM EDT | Rise Nano Optics Ltd.
Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL
Northvale, New Jersey--(Newsfile Corp. - August 4, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Requip XL® (Ropinirole Extended-Release Tablets USP), with strengths of 2 mg, 4 mg, 6 mg, 8 mg, and 12 mg tablets. Ropinirole belongs to a class of drugs known as a non-ergoline dopamine agonist used to treat P
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-04 7:00 AM EDT | Elite Pharmaceuticals, Inc.
TempraMed Announces Strategic Partnership with Stealth Health, a Leading Telemedicine Platform for Longevity and Wellness
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce a strategic partnership with Stealth Health (stealth.health), a leading telemedicine platform for longevity and precision wellness in North America. The agreement integrates TempraMed's VIVI product portfolio into
Technology, Biotechnology, Pharmaceuticals, Health
2026-08-04 7:00 AM EDT | TempraMed Technologies Ltd.
WELL Health Strengthens Executive Leadership Team with Appointments of Loreto Grimaldi as Chief Legal Officer and Kaytek Przybylski as Chief Digital & Information Officer
WELL appoints accomplished legal and business executive Loreto Grimaldi as Chief Legal Officer to lead legal, compliance, governance, risk management and M&A activities across the organization. Seasoned technology and digital transformation leader Kaytek Przybylski joins WELL as Chief Digital & Information Officer to lead enterprise technology, digital transformation, data, AI, and cybersecurity and technology shared services strategy.
Technology, Computer Software, Healthcare and Hospitals, Health
2026-08-04 6:30 AM EDT | WELL Health Technologies Corp.
Edison Group Reaches Global Audience of over 8.5 Million
London, United Kingdom--(Newsfile Corp. - August 4, 2026) - Edison Group, the leading global investor relations and research firm, today announced a major milestone: over the past 12 months, its content generated more than 8.5m investor engagements, views and reads from investors across all pools of capital, in every financial centre and beyond.
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-08-04 6:02 AM EDT | Edison Group
WELL Health to Announce Second Quarter 2026 Financial Results on August 6, 2026
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal Second Quarter 2026 financial results for the period ended June 30, 2026, after market close on Thursd
Technology, Computer Software, Healthcare and Hospitals, Health
2026-08-04 6:00 AM EDT | WELL Health Technologies Corp.
Defence Therapeutics Appoints Dr. Amie Phinney as President and Chief Executive Officer
Montreal, Quebec--(Newsfile Corp. - August 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® technology, is pleased to announce the appointment of Dr. Amie Phinney, PhD, MBA, as the President and Chief Executive Officer, effective August 1, 2026. As part of the leadership transitio
Biotechnology, Pharmaceuticals, Health
2026-08-04 3:15 AM EDT | Defence Therapeutics Inc.
Verisante Technology, Inc. Announces Resignation of Director
Vancouver, British Columbia--(Newsfile Corp. - August 3, 2026) - Verisante Technology, Inc. (TSXV: VER.H) ("Verisante" or the "Company") announces that Dr. Jake Thiessen, PhD has resigned as a director of the Company effective August 3, 2026. "On behalf of the Board of Directors, I want to sincerely thank Dr. Thiessen for his dedication and contributions to Verisante," said Thomas Braun, Chief Executive Officer. The Company confirms that there are no matters referred to in
2026-08-03 11:51 PM EDT | Verisante Technology Inc.
WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. ("WELLSTAR"), has closed a financing transaction for aggregate gross proceeds of C$50 million (the "Financing
Technology, Computer Software, Healthcare and Hospitals, Health
2026-07-31 8:17 AM EDT | WELL Health Technologies Corp.
Jack Nathan Medical Corp. Announces Board Changes and Corporate Update
Toronto, Ontario--(Newsfile Corp. - July 31, 2026) - Jack Nathan Medical Corp. (TSXV: JNH) (OTC Pink: JNHMF) ("Jack Nathan" or the "Company") announces that Blake Lyon, Chairman of the Board of Directors, and Anthony DeCristofaro, Director, have resigned from the Board of Directors of the Company (the "Board"), effective July 31, 2026. Mr. Lyon and Mr. DeCristofaro have each served the Company for many years and have contributed significant time, leadership and experience throughout the
Healthcare and Hospitals, Retail, Health
2026-07-31 6:00 AM EDT | Jack Nathan Medical Corp.
Edison Issues Report on Kooth (KOO)
London, United Kingdom--(Newsfile Corp. - July 31, 2026) - Edison issues report on Kooth (AIM: KOO) Kooth provides clinically accredited digital mental health support, focused on children and young adults. H126 trading was in line with expectations. Adjusted EBITDA is expected to rise to £5.0-5.4m (H125: £1.6m), implying a c 17% margin (H125: 5%) as strong California user engagement compares with a prior year that included accelerated investment. Revenue is expected to be
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-07-31 5:18 AM EDT | Edison Group